0001193125-18-287253.txt : 20180928 0001193125-18-287253.hdr.sgml : 20180928 20180928145606 ACCESSION NUMBER: 0001193125-18-287253 CONFORMED SUBMISSION TYPE: N-Q PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20180731 FILED AS OF DATE: 20180928 DATE AS OF CHANGE: 20180928 EFFECTIVENESS DATE: 20180928 FILER: COMPANY DATA: COMPANY CONFORMED NAME: OPPENHEIMER SERIES FUND CENTRAL INDEX KEY: 0000356865 IRS NUMBER: 061207374 STATE OF INCORPORATION: DE FISCAL YEAR END: 1031 FILING VALUES: FORM TYPE: N-Q SEC ACT: 1940 Act SEC FILE NUMBER: 811-03346 FILM NUMBER: 181093831 BUSINESS ADDRESS: STREET 1: 6803 SOUTH TUCSON WAY STREET 2: N/A CITY: CENTENNIAL STATE: CO ZIP: 80112-3924 BUSINESS PHONE: 303-768-3200 MAIL ADDRESS: STREET 1: 6803 SOUTH TUCSON WAY STREET 2: N/A CITY: CENTENNIAL STATE: CO ZIP: 80112-3924 FORMER COMPANY: FORMER CONFORMED NAME: OPPENHEIMER SERIES FUND INC DATE OF NAME CHANGE: 19960909 FORMER COMPANY: FORMER CONFORMED NAME: CONNECTICUT MUTUAL INVESTMENT ACCOUNTS INC DATE OF NAME CHANGE: 19920703 FORMER COMPANY: FORMER CONFORMED NAME: CONNECTICUT MUTUAL LIQUID ACCOUNT INC DATE OF NAME CHANGE: 19851106 0000356865 S000007309 Oppenheimer Value Fund C000020080 A C000020081 B C000020082 C C000020083 R C000033091 Y C000110989 I N-Q 1 d619910dnq.htm N-Q N-Q

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

FORM N-Q

 

 

QUARTERLY SCHEDULE OF PORTFOLIO HOLDINGS

OF REGISTERED MANAGEMENT INVESTMENT COMPANY

Investment Company Act file number 811-3346

 

 

Oppenheimer Series Fund

(Exact name of registrant as specified in charter)

 

 

6803 South Tucson Way, Centennial, Colorado 80112-3924

(Address of principal executive offices) (Zip code)

 

 

Cynthia Lo Bessette

OFI Global Asset Management, Inc.

225 Liberty Street, New York, New York 10281-1008

(Name and address of agent for service)

 

 

Registrant’s telephone number, including area code: (303) 768-3200

Date of fiscal year end: October 31

Date of reporting period: 7/31/2018

 

 

 


Item 1. Schedule of Investments.

 


STATEMENT OF INVESTMENTS July 31, 2018 Unaudited

 

 

      Shares      Value  

Common Stocks—97.8%

 

        

Consumer Discretionary—7.9%

 

        
Auto Components—0.7%

 

  

BorgWarner, Inc.

 

    

 

329,100

 

 

 

   $

 

15,145,182

 

 

 

Automobiles—1.5%

 

  

General Motors Co.

 

    

 

791,060

 

 

 

    

 

29,989,085

 

 

 

Hotels, Restaurants & Leisure—1.2%

 

  
Las Vegas Sands Corp.      119,370        8,582,703  
McDonald’s Corp.      100,850        15,887,909  
     

 

 

 

               

 

          24,470,612

 

 

 

Household Durables—0.4%

 

  

Lennar Corp., Cl. A

 

    

 

154,100

 

 

 

    

 

8,054,807

 

 

 

Media—1.8%

 

  
CBS Corp., Cl. B      251,500        13,246,505  
Walt Disney Co. (The)      196,922        22,362,462  
     

 

 

 

               

 

35,608,967

 

 

 

Multiline Retail—1.7%

 

  

Target Corp.

 

    

 

435,920

 

 

 

    

 

35,170,026

 

 

 

Specialty Retail—0.6%

 

  

Lowe’s Cos., Inc.

 

    

 

114,710

 

 

 

    

 

11,395,291

 

 

 

Consumer Staples—6.9%

 

        
Beverages—3.0%

 

  
Coca-Cola Co. (The)      869,340        40,537,324  
Coca-Cola European Partners plc      524,420        21,627,081  
     

 

 

 

               

 

62,164,405

 

 

 

Food & Staples Retailing—1.6%

 

  

Walmart, Inc.

 

    

 

360,270

 

 

 

    

 

32,146,892

 

 

 

Food Products—0.3%

 

  

General Mills, Inc.

 

    

 

134,680

 

 

 

    

 

6,203,361

 

 

 

Household Products—0.6%

 

  

Procter & Gamble Co. (The)

 

    

 

143,360

 

 

 

    

 

11,594,957

 

 

 

Tobacco—1.4%

 

  

Philip Morris International, Inc.

 

    

 

335,770

 

 

 

    

 

28,976,951

 

 

 

Energy—13.1%

 

        
Energy Equipment & Services—2.1%

 

  
Halliburton Co.      223,513        9,481,422  
Weatherford International plc1      9,851,760        33,397,466  
     

 

 

 

        42,878,888  
      Shares      Value  

Oil, Gas & Consumable Fuels—11.0%

 

  
Chevron Corp.      539,156      $ 68,079,228  
Concho Resources, Inc.1      90,150        13,148,377  
ConocoPhillips      523,868        37,807,554  
Enbridge, Inc.      431,317        15,281,561  
Phillips 66      165,022        20,353,813  
Suncor Energy, Inc.      1,624,990        68,477,079  
     

 

 

 

               

 

        223,147,612

 

 

 

Financials—27.5%

 

        
Capital Markets—5.8%

 

  
Ameriprise Financial, Inc.      116,860        17,022,996  
BlackRock, Inc., Cl. A      58,770        29,547,205  
Goldman Sachs Group, Inc. (The)      149,780        35,562,266  
Nasdaq, Inc.      385,330        35,219,162  
     

 

 

 

               

 

117,351,629

 

 

 

Commercial Banks—15.5%

 

  
Bank of America Corp.      3,168,600        97,846,368  
CIT Group, Inc.      310,280        16,423,120  
Citigroup, Inc.      717,650        51,591,859  
JPMorgan Chase & Co.      720,460        82,816,877  
KeyCorp      1,393,200        29,076,084  
Zions Bancorporation      716,130        37,023,921  
     

 

 

 

               

 

314,778,229

 

 

 

Insurance—2.1%

 

  
Aon plc      106,600        15,302,430  
Hartford Financial Services Group, Inc. (The)      530,040        27,933,108  
     

 

 

 

               

 

43,235,538

 

 

 

Real Estate Investment Trusts (REITs)—4.1%

 

  
Crown Castle International Corp.      179,410        19,884,010  
Digital Realty Trust, Inc.      116,040        14,089,577  
Equity Residential      204,020        13,349,028  
Prologis, Inc.      416,510        27,331,386  
Public Storage      34,590        7,534,740  
     

 

 

 

               

 

82,188,741

 

 

 

Health Care—15.8%

 

        
Biotechnology—1.3%

 

  
Amgen, Inc.      41,960        8,247,238  
 

 

1      OPPENHEIMER VALUE FUND


STATEMENT OF INVESTMENTS Unaudited / Continued

 

 

      Shares      Value  
Biotechnology (Continued)

 

        
Gilead Sciences, Inc.      236,950      $ 18,441,819  
     

 

 

 

               

 

26,689,057

 

 

 

Health Care Equipment & Supplies—4.0%

 

  
Abbott Laboratories      379,230        24,854,734  
Boston Scientific Corp.1      603,530        20,284,643  
Danaher Corp.      251,634        25,812,616  
Zimmer Biomet Holdings, Inc.      90,600        11,372,112  
     

 

 

 

               

 

          82,324,105

 

 

 

Health Care Providers & Services—4.1%

 

  
Anthem, Inc.      40,650        10,284,450  
UnitedHealth Group, Inc.      287,811        72,879,502  
     

 

 

 

               

 

83,163,952

 

 

 

Life Sciences Tools & Services—1.2%

 

  

Thermo Fisher Scientific, Inc.

 

    

 

100,840

 

 

 

    

 

23,650,005

 

 

 

Pharmaceuticals—5.2%

 

  
Bristol-Myers Squibb Co.      176,350        10,360,562  
Merck & Co., Inc.      588,010        38,732,219  
Mylan NV1      433,520        16,174,631  
Pfizer, Inc.      1,013,100        40,453,083  
     

 

 

 

               

 

105,720,495

 

 

 

Industrials—7.7%

 

        
Aerospace & Defense—0.9%

 

  

Lockheed Martin Corp.

 

    

 

54,650

 

 

 

    

 

17,821,365

 

 

 

Air Freight & Couriers—1.4%

 

  
FedEx Corp.      52,790        12,979,477  
XPO Logistics, Inc.1      166,410        16,594,405  
     

 

 

 

                29,573,882  
Commercial Services & Supplies—0.8%

 

  

Waste Management, Inc.

 

    

 

182,850

 

 

 

    

 

16,456,500

 

 

 

Construction & Engineering—0.4%

 

  

Fluor Corp.

 

    

 

161,090

 

 

 

    

 

8,255,863

 

 

 

Industrial Conglomerates—0.6%

 

  

General Electric Co.

 

    

 

850,310

 

 

 

    

 

11,589,725

 

 

 

Machinery—2.9%      
Caterpillar, Inc.      134,580        19,352,604  
Deere & Co.      73,170        10,594,285  
      Shares      Value  
Machinery (Continued)

 

        
Parker-Hannifin Corp.      169,865      $ 28,715,678  
     

 

 

 

               

 

58,662,567

 

 

 

Road & Rail—0.7%

 

  

Kansas City Southern

 

    

 

121,900

 

 

 

    

 

14,173,313

 

 

 

Information Technology—8.0%

 

        
Communications Equipment—2.2%

 

  

Cisco Systems, Inc.

 

    

 

1,028,350

 

 

 

    

 

43,488,921

 

 

 

Electronic Equipment, Instruments, & Components—1.1%

 

TE Connectivity Ltd.      159,137        14,890,449  
Zebra Technologies Corp., Cl. A1      55,430        7,645,460  
     

 

 

 

               

 

          22,535,909

 

 

 

Internet Software & Services—0.3%

 

  

Alphabet, Inc., Cl. A1

 

    

 

4,050

 

 

 

    

 

4,970,241

 

 

 

Semiconductors & Semiconductor Equipment—1.3%

 

Marvell Technology Group Ltd.      667,690        14,228,474  
Texas Instruments, Inc.      116,650        12,985,478  
     

 

 

 

               

 

27,213,952

 

 

 

Software—2.5%

 

  
Microsoft Corp.      281,700        29,882,736  
Synopsys, Inc.1      241,890        21,632,223  
     

 

 

 

               

 

51,514,959

 

 

 

Technology Hardware, Storage & Peripherals—0.6%

 

HP, Inc.

 

    

 

524,240

 

 

 

    

 

12,099,459

 

 

 

Materials—4.1%

 

        
Chemicals—1.7%

 

  

Eastman Chemical Co.

 

    

 

333,475

 

 

 

    

 

34,554,679

 

 

 

Containers & Packaging—1.0%

 

  

WestRock Co.

 

    

 

352,550

 

 

 

    

 

20,440,849

 

 

 

Metals & Mining—1.4%

 

  
Alcoa Corp.1      406,400        17,584,928  
Freeport-McMoRan, Inc.      637,410        10,517,265  
     

 

 

 

        28,102,193  
 

 

2      OPPENHEIMER VALUE FUND


 

 

      Shares     Value  

Telecommunication Services—2.2%

 

       

Diversified Telecommunication Services—2.2%

 

AT&T, Inc.

    

 

1,396,290

 

 

 

  $

 

44,639,391  

 

 

 

Utilities—4.6%

 

       

Electric Utilities—4.6%

 

Edison International

     427,470       28,482,326  

Entergy Corp.

     394,320       32,050,330  

NextEra Energy, Inc.

     191,313       32,052,580  
    

 

 

 

       92,585,236  
    

 

 

 

Total Common Stocks

(Cost $1,549,843,328)

               1,984,727,791  
      Shares      Value  

Investment Company—1.5%

 

        

Oppenheimer Institutional Government Money Market Fund, Cl. E, 1.87%2,3 (Cost $31,391,308)

 

    

 

31,391,308

 

 

 

   $

 

31,391,308

 

 

 

Total Investments, at Value (Cost $1,581,234,636)      99.3%        2,016,119,099  
Net Other Assets (Liabilities)      0.7        13,211,740  
Net Assets      100.0%      $         2,029,330,839  
                 
 

Footnotes to Statement of Investments

1. Non-income producing security.

2. Rate shown is the 7-day yield at period end.

3. Is or was an affiliate, as defined in the Investment Company Act of 1940, as amended, at or during the reporting period, by virtue of the Fund owning at least 5% of the voting securities of the issuer or as a result of the Fund and the issuer having the same investment adviser. Transactions during the reporting period in which the issuer was an affiliate are as follows:

     Shares      Gross     Gross      Shares  
      October 31, 2017      Additions     Reductions      July 31, 2018  
Investment Company           
Oppenheimer Institutional Government Money Market Fund, Cl. E      32,591,527                356,883,566               358,083,785                31,391,308  
                         Change in  
                  Realized      Unrealized  
      Value      Income     Gain (Loss)      Gain (Loss)  
Investment Company           
Oppenheimer Institutional Government Money Market Fund, Cl. E    $ 31,391,308      $ 338,695     $      $  

 

3      OPPENHEIMER VALUE FUND


NOTES TO STATEMENT OF INVESTMENTS July 31, 2018 Unaudited

 

 

 

1. Organization

Oppenheimer Value Fund (the “Fund”), a series of Oppenheimer Series Fund, is registered under the Investment Company Act of 1940 (“1940 Act”), as amended, as a diversified open-end management investment company. The Fund’s investment objective is to seek capital appreciation. The Fund’s investment adviser is OFI Global Asset Management, Inc. (“OFI Global” or the “Manager”), a wholly-owned subsidiary of OppenheimerFunds, Inc. (“OFI” or the “Sub-Adviser”). The Manager has entered into a sub-advisory agreement with OFI.

 

 

2. Securities Valuation

The Fund calculates the net asset value of its shares as of 4:00 P.M. Eastern Time, on each day the New York Stock Exchange (the “Exchange”) is open for trading, except in the case of a scheduled early closing of the Exchange, in which case the Fund will calculate net asset value of the shares as of the scheduled early closing time of the Exchange.

The Fund’s Board has adopted procedures for the valuation of the Fund’s securities and has delegated the day-to-day responsibility for valuation determinations under those procedures to the Manager. The Manager has established a Valuation Committee which is responsible for determining a fair valuation for any security for which market quotations are not readily available. The Valuation Committee’s fair valuation determinations are subject to review, approval and ratification by the Fund’s Board at least quarterly or more frequently, if necessary.

Valuation Methods and Inputs

Securities are valued primarily using unadjusted quoted market prices, when available, as supplied by third party pricing services or broker-dealers.

The following methodologies are used to determine the market value or the fair value of the types of securities described below:

Equity securities traded on a securities exchange (including exchange-traded derivatives other than futures and futures options) are valued based on the official closing price on the principal exchange on which the security is traded, as identified by the Manager, prior to the time when the Fund’s assets are valued. If the official closing price is unavailable, the security is valued at the last sale price on the principal exchange on which it is traded, or if no sales occurred, the security is valued at the mean between the quoted bid and asked prices. Over-the-counter equity securities are valued at the last published sale price, or if no sales occurred, at the mean between the quoted bid and asked prices. Events occurring after the close of trading on foreign exchanges may result in adjustments to the valuation of foreign securities to more accurately reflect their fair value as of the time when the Fund’s assets are valued.

Shares of a registered investment company that are not traded on an exchange are valued at that investment company’s net asset value per share.

Securities for which market quotations are not readily available, or when a significant event has occurred that would materially affect the value of the security, are fair valued either (i) by a standardized fair valuation methodology applicable to the security type or the significant event as previously approved by the Valuation Committee and the Fund’s Board or (ii) as determined in good faith by the Manager’s Valuation Committee. The Valuation Committee

 

 

4      OPPENHEIMER VALUE FUND


        

 

 

 

2. Securities Valuation (Continued)

considers all relevant facts that are reasonably available, through either public information or information available to the Manager, when determining the fair value of a security. Those standardized fair valuation methodologies include, but are not limited to, valuing securities at the last sale price or initially at cost and subsequently adjusting the value based on: changes in company specific fundamentals, changes in an appropriate securities index, or changes in the value of similar securities which may be further adjusted for any discounts related to security-specific resale restrictions. When possible, such methodologies use observable market inputs such as unadjusted quoted prices of similar securities, observable interest rates, currency rates and yield curves. The methodologies used for valuing securities are not necessarily an indication of the risks associated with investing in those securities nor can it be assured that the Fund can obtain the fair value assigned to a security if it were to sell the security.

Classifications

Each investment asset or liability of the Fund is assigned a level at measurement date based on the significance and source of the inputs to its valuation. Various data inputs may be used in determining the value of each of the Fund’s investments as of the reporting period end.

These data inputs are categorized in the following hierarchy under applicable financial accounting standards:

1) Level 1-unadjusted quoted prices in active markets for identical assets or liabilities (including securities actively traded on a securities exchange)

2) Level 2-inputs other than unadjusted quoted prices that are observable for the asset or liability (such as unadjusted quoted prices for similar assets and market corroborated inputs such as interest rates, prepayment speeds, credit risks, etc.)

3) Level 3-significant unobservable inputs (including the Manager’s own judgments about assumptions that market participants would use in pricing the asset or liability).

The inputs used for valuing securities are not necessarily an indication of the risks associated with investing in those securities.

The Fund classifies each of its investments in investment companies which are publicly offered as Level 1. Investment companies that are not publicly offered, if any, are classified as Level 2 in the fair value hierarchy.

The table below categorizes amounts at period end based on valuation input level:

 

    

Level 1—

Unadjusted
Quoted Prices

     Level 2—
Other Significant
Observable Inputs
     Level 3—
Significant
Unobservable
Inputs
     Value  

Assets Table

          

Investments, at Value:

          

Common Stocks

          

Consumer Discretionary

  $             159,833,970      $                             —      $                     —      $             159,833,970  

Consumer Staples

    141,086,566                      141,086,566  

Energy

    266,026,500                      266,026,500  

 

5      OPPENHEIMER VALUE FUND


NOTES TO STATEMENT OF INVESTMENTS Unaudited / Continued

 

 

 

2. Securities Valuation (Continued)

 

    Level 1—
Unadjusted
Quoted Prices
     Level 2—
Other Significant
Observable Inputs
     Level 3—
Significant
Unobservable
Inputs
     Value    

 

 

Common Stocks (Continued)

          

Financials

  $ 557,554,137      $             —      $             —      $ 557,554,137    

Health Care

    321,547,614                      321,547,614    

Industrials

    156,533,215                      156,533,215    

Information Technology

    161,823,441                      161,823,441    

Materials

    83,097,721                      83,097,721    

Telecommunication Services

    44,639,391                      44,639,391    

Utilities

    92,585,236                      92,585,236    
Investment Company     31,391,308                      31,391,308    
 

 

 

 

Total Assets

  $     2,016,119,099      $      $      $     2,016,119,099    
 

 

 

 

Forward currency exchange contracts and futures contracts, if any, are reported at their unrealized appreciation/depreciation at measurement date, which represents the change in the contract’s value from trade date. All additional assets and liabilities included in the above table are reported at their market value at measurement date.

For the reporting period, there were no transfers between levels.

 

 

3. Investments and Risks

Investments in Affiliated Funds. The Fund is permitted to invest in other mutual funds advised by the Manager (“Affiliated Funds”). Affiliated Funds are open-end management investment companies registered under the 1940 Act, as amended. The Manager is the investment adviser of, and the Sub-Adviser provides investment and related advisory services to, the Affiliated Funds. When applicable, the Fund’s investments in Affiliated Funds are included in the Statement of Investments. Shares of Affiliated Funds are valued at their net asset value per share. As a shareholder, the Fund is subject to its proportional share of the Affiliated Funds’ expenses, including their management fee. The Manager will waive fees and/ or reimburse Fund expenses in an amount equal to the indirect management fees incurred through the Fund’s investment in the Affiliated Funds.

Each of the Affiliated Funds in which the Fund invests has its own investment risks, and those risks can affect the value of the Fund’s investments and therefore the value of the Fund’s shares. To the extent that the Fund invests more of its assets in one Affiliated Fund than in another, the Fund will have greater exposure to the risks of that Affiliated Fund.

Investments in Money Market Instruments. The Fund is permitted to invest its free cash balances in money market instruments to provide liquidity or for defensive purposes. The Fund may invest in money market instruments by investing in Class E shares of Oppenheimer Institutional Government Money Market Fund (“IGMMF”), which is an Affiliated Fund. IGMMF is regulated as a money market fund under the 1940 Act, as amended. The Fund may also invest in money market instruments directly or in other affiliated or unaffiliated money market funds.

 

6      OPPENHEIMER VALUE FUND


        

 

 

 

3. Investments and Risks (Continued)

Equity Security Risk. Stocks and other equity securities fluctuate in price. The value of the Fund’s portfolio may be affected by changes in the equity markets generally. Equity markets may experience significant short-term volatility and may fall sharply at times. Different markets may behave differently from each other and U.S. equity markets may move in the opposite direction from one or more foreign stock markets. Adverse events in any part of the equity or fixed-income markets may have unexpected negative effects on other market segments.

The prices of individual equity securities generally do not all move in the same direction at the same time and a variety of factors can affect the price of a particular company’s securities. These factors may include, but are not limited to, poor earnings reports, a loss of customers, litigation against the company, general unfavorable performance of the company’s sector or industry, or changes in government regulations affecting the company or its industry.

 

 

4. Market Risk Factors

The Fund’s investments in securities and/or financial derivatives may expose the Fund to various market risk factors:

Commodity Risk. Commodity risk relates to the change in value of commodities or commodity indexes as they relate to increases or decreases in the commodities market. Commodities are physical assets that have tangible properties. Examples of these types of assets are crude oil, heating oil, metals, livestock, and agricultural products.

Credit Risk. Credit risk relates to the ability of the issuer of debt to meet interest and principal payments, or both, as they come due. In general, lower-grade, higher-yield debt securities are subject to credit risk to a greater extent than lower-yield, higher-quality securities.

Equity Risk. Equity risk relates to the change in value of equity securities as they relate to increases or decreases in the general market.

Foreign Exchange Rate Risk. Foreign exchange rate risk relates to the change in the U.S. dollar value of a security held that is denominated in a foreign currency. The U.S. dollar value of a foreign currency denominated security will decrease as the dollar appreciates against the currency, while the U.S. dollar value will increase as the dollar depreciates against the currency.

Interest Rate Risk. Interest rate risk refers to the fluctuations in value of fixed-income securities resulting from the inverse relationship between price and yield. For example, an increase in general interest rates will tend to reduce the market value of already issued fixed-income investments, and a decline in general interest rates will tend to increase their value. In addition, debt securities with longer maturities, which tend to have higher yields, are subject to potentially greater fluctuations in value from changes in interest rates than obligations with shorter maturities.

Volatility Risk. Volatility risk refers to the magnitude of the movement, but not the direction of the movement, in a financial instrument’s price over a defined time period. Large increases or decreases in a financial instrument’s price over a relative time period typically indicate greater volatility risk, while small increases or decreases in its price

 

7      OPPENHEIMER VALUE FUND


NOTES TO STATEMENT OF INVESTMENTS Unaudited / Continued

 

 

 

4. Market Risk Factors (Continued)

typically indicate lower volatility risk.

 

8      OPPENHEIMER VALUE FUND


Item 2. Controls and Procedures.

 

  (a)

Based on their evaluation of the registrant’s disclosure controls and procedures (as defined in rule 30a-3(c) under the Investment Company Act of 1940 (17 CFR 270.30a-3(c)) as of 7/31/2018, the registrant’s principal executive officer and principal financial officer found the registrant’s disclosure controls and procedures to provide reasonable assurances that information required to be disclosed by the registrant in the reports that it files under the Securities Exchange Act of 1934 (a) is accumulated and communicated to the registrant’s management, including its principal executive officer and principal financial officer, to allow timely decisions regarding required disclosure, and (b) is recorded, processed, summarized and reported, within the time periods specified in the rules and forms adopted by the U.S. Securities and Exchange Commission.

 

  (b)

There have been no significant changes in the registrant’s internal controls over financial reporting that occurred during the registrant’s last fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting.

Item 3. Exhibits.

Exhibits attached hereto.

 


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Oppenheimer Series Fund

 

By:  

/s/ Arthur P. Steinmetz

  Arthur P. Steinmetz
  Principal Executive Officer
Date:   9/21/2018

Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

 

By:  

/s/ Arthur P. Steinmetz

  Arthur P. Steinmetz
  Principal Executive Officer
Date:   9/21/2018

 

By:  

/s/ Brian S. Petersen

  Brian S. Petersen
  Principal Financial Officer
Date:   9/21/2018

 

EX-99.CERT 2 d619910dex99cert.htm SECTION 302 CERTIFICATIONS Section 302 Certifications

Exhibit 99.CERT

Section 302 Certifications

CERTIFICATIONS

I, Arthur P. Steinmetz, certify that:

 

1.

I have reviewed this report on Form N-Q of Oppenheimer Series Fund;

 

2.

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.

Based on my knowledge, the schedules of investments included in this report fairly present in all material respects the investments of the registrant as of the end of the fiscal quarter for which the report is filed;

 

4.

The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Rule 30a-3(c) under the Investment Company Act of 1940) and internal control over financial reporting (as defined in Rule 30a-3(d) under the Investment Company Act of 1940) for the registrant and have:

 

  (a)

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

  (b)

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

  (c)

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of a date within 90 days prior to the filing date of this report, based on such evaluation; and

 

  (d)

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and


5.

The registrant’s other certifying officer and I have disclosed to the registrant’s auditors and the audit committee of the registrant’s board of Trustees (or persons performing the equivalent functions):

 

  (a)

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize, and report financial information; and

 

  (b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

/s/ Arthur P. Steinmetz

Arthur P. Steinmetz
Principal Executive Officer
Date: 9/21/2018


Exhibit 99.CERT

Section 302 Certifications

CERTIFICATIONS

I, Brian S. Petersen, certify that:

 

1.

I have reviewed this report on Form N-Q of Oppenheimer Series Fund;

 

2.

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.

Based on my knowledge, the schedules of investments included in this report fairly present in all material respects the investments of the registrant as of the end of the fiscal quarter for which the report is filed;

 

4.

The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Rule 30a-3(c) under the Investment Company Act of 1940) and internal control over financial reporting (as defined in Rule 30a-3(d) under the Investment Company Act of 1940) for the registrant and have:

 

  (a)

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

  (b)

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

  (c)

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of a date within 90 days prior to the filing date of this report, based on such evaluation; and

 

  (d)

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and


5.

The registrant’s other certifying officer and I have disclosed to the registrant’s auditors and the audit committee of the registrant’s board of Trustees (or persons performing the equivalent functions):

 

  (a)

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize, and report financial information; and

 

  (b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

/s/ Brian S. Petersen

Brian S. Petersen

Principal Financial Officer

Date: 9/21/2018